rosiglitazone has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinney, CP; Ferguson, JE; Kamat, AM; Li, R; McConkey, DJ; Metcalfe, MJ; Mokkapati, S; Navai, N; Nogueras González, GM; Sahai, SK | 1 |
| Attalla, B; Bergholm, AM; Billger, M; Chadwick, KD; Chen, SJ; Czajkowski, M; Dorr, T; Foster, JR; Granaldi, K; Graziano, M; Haile, S; Janovitz, E; Mangipudy, R; Söderberg, M; Song, Y; Tirmenstein, M | 1 |
2 other study(ies) available for rosiglitazone and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Effects of thiazolidinedione in patients with active bladder cancer.
Topics: Aged; Carcinoma, Transitional Cell; Cystectomy; Diabetes Mellitus; Disease-Free Survival; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Neoplasm Staging; Pioglitazone; Retrospective Studies; Rosiglitazone; Survival Rate; Thiazolidinediones; Urinary Bladder Neoplasms | 2018 |
Evaluation of Uracil, Sodium Ascorbate, and Rosiglitazone as Promoters of Urinary Bladder Transitional Cell Carcinomas in Male Sprague-Dawley Rats.
Topics: Animals; Ascorbic Acid; Carcinogens; Carcinoma, Transitional Cell; Disease Models, Animal; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Uracil; Urinary Bladder; Urinary Bladder Neoplasms | 2018 |